ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

GRFS Grifols SA

6.38
0.11 (1.75%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Grifols SA GRFS NASDAQ Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.11 1.75% 6.38 15:00:13
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
6.36 6.29 6.505 6.38 6.27
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
19/4/202415:42PRNUSGrifols 2023 Annual Report on Form 20-F filed with the SEC
18/4/202408:30GLOBEGrifols Celebrates 50 Years of Manufacturing Life-Changing..
15/4/202406:06IHMARKETNEWSSamsung Surpasses Apple in Q1 Smartphone Market; Salesforce..
04/4/202403:00GLOBEGrifols Procleix ArboPlex Assay® Receives CE Mark, the First..
22/3/202408:07IHMARKETNEWSFedEx Soars 13% with Profits Above Forecasts, Nike Hit by..
08/3/202405:19IHMARKETNEWSCNOOC Oil Field Discovery in South China Sea, Grifols Surges..
14/2/202402:16GLOBEGrifols announces positive topline phase 3 fibrinogen..
26/1/202416:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/1/202405:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/1/202405:10IHMARKETNEWSWall Street Highlights: DocuSign Acquisition Battle, Tesla..
10/1/202412:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/1/202407:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/1/202405:21IHMARKETNEWSWall Street Highlights: Tesla Launches Restyled Model 3,..
09/1/202413:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/1/202407:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/12/202308:59DJNGrifols Shares Rise on $1.76 Billion Sale of 20% Stake in..
29/12/202308:46EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/12/202308:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202304:00PRNUSGrifols launches new solution to facilitate pre-transfusion..
15/11/202307:00GLOBEGrifols Completes Cohort 1 in Clinical Study of Alpha-1 15%,..
06/11/202307:00GLOBEGigaGen Presents IND-Enabling Data and Phase 1 Trial..
02/11/202312:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/10/202317:30GLOBEAraclon Biotech Presents Positive Final Results from Phase 2..
20/10/202307:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/10/202307:00GLOBEGigaGen Granted Expansion of Contract with US Department of..
28/9/202307:00GLOBEGigaGen Partners with the National Cancer Institute to..
01/8/202307:00GLOBEGrifols Accelerates Healthcare Innovation with Google..
27/7/202310:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/7/202307:15GLOBEGrifols Achieves Positive Topline Results From Phase 4 Study..
18/7/202307:00GLOBEGrifols Completes Enrollment in Phase 3 Study of Long-term..
13/7/202307:00GLOBEGrifols Meets Enrollment Target in Phase 3 Study of Two Dose..
14/6/202318:34DJNADRs End Higher, Grifols, Victrex Trade Actively
14/6/202305:44DJNGrifols Shares Rise on Potential Sale of Shanghai RAAS Stock..
11/5/202307:30GLOBEGrifols Launches AlphaID™ At Home, Enabling U.S. Consumers..
09/5/202318:31DJNADRs End Mostly Lower, Natura & Co. and Grifols Trade..

Su Consulta Reciente

Delayed Upgrade Clock